What is Rifampicin ($RIF)?

Quick Facts

  • Blockchain: Solana
  • Platform: Pump Science (developed by Molecule)
  • Category: Decentralized Science (DeSci)
  • Token role: Represents IP and experimental rights for Rifampicin research
  • Research focus: Longevity and anti-aging compounds
  • Model organisms used: C. elegans (roundworms) and fruit flies
  • Experiment format: Live-streamed, real-time data accessible to token holders

Introduction

Rifampicin ($RIF) is a DeSci token on the Solana blockchain that bridges cryptocurrency and scientific research. It represents tokenized ownership of longevity experiments centered on the compound Rifampicin — a substance traditionally known as an antibiotic that has drawn growing attention for its potential anti-aging effects.

The token is hosted on Pump Science, a gamified longevity research platform where participants can speculate on life-extending compounds, observe live experiment data, and propose their own longevity tests.

History & Background

Pump Science was developed by Molecule, a biotechnology research fundraising organization co-founded by Tyler Golato and Paul Kohlhaas. The platform launched in 2024 on Solana, positioning itself as a token launchpad for research compounds being investigated for their life-extending properties.

$RIF was among the first tokens launched on the platform, representing the compound Rifampicin and its associated research pipeline.

How Rifampicin Works

Rifampicin the compound has been shown to activate natural cellular defense mechanisms against stress and damage in model organisms like C. elegans. It helps cells manage oxidative stress and maintain protein quality — effects that contribute to longer, healthier lifespans in these organisms.

On the blockchain side, the $RIF token functions as a stake in these experiments. Transaction fees generated by the token directly fund ongoing scientific research. Experiment results are live-streamed, giving token holders real-time visibility into findings.

Tokenomics

$RIF operates on a community-funded research model. Token activity — buying, selling, and trading — generates fees that flow back into financing further experiments. The economic design aligns speculative market participation with genuine scientific progress, creating a feedback loop between community engagement and research outcomes.

Token holders gain fractional rights to the intellectual property generated by successful experiments, potentially including supplements or research chemicals derived from Rifampicin.

Circulating Supply ? 999.24 million $RIF
Total supply ? 999.24 million $RIF
Max supply ? -- $RIF
Updated 16h ago

Ecosystem & Use Cases

Within the Pump Science ecosystem, $RIF holders can:

  • Monitor live-streamed experiment data in real time
  • Fund new research milestones as experiments progress
  • Participate in a growing DeSci community focused on longevity
  • Propose new longevity cocktails for testing on model organisms

Team, Governance & Community

The project is backed by Molecule, an established name in the decentralized science space focused on democratizing research funding. The Pump Science platform governs experiment selection and research direction, with community input shaping which compounds and longevity hypotheses receive attention.

Advantages

  • Real scientific grounding: Backed by legitimate longevity research on established model organisms
  • Transparent data: Live-streamed experiments give holders direct visibility into research progress
  • Community-funded model: Token activity directly finances scientific work
  • Established backing: Developed by Molecule, a credible DeSci organization
  • Fast, low-cost network: Built on Solana for efficient transactions

Risks & Challenges

  • Early-stage science: Longevity research in model organisms does not guarantee human applications
  • Speculative market: The DeSci sector carries volatility risks similar to meme tokens
  • Regulatory uncertainty: Tokenized IP and research rights exist in a largely uncharted legal space
  • Niche ecosystem: Audience overlap between crypto speculators and longevity enthusiasts remains limited

Long-Term Vision

The long-term ambition of $RIF and Pump Science is to commercialize and license compounds proven effective in extending lifespan. If Rifampicin's anti-aging effects are validated at higher organism levels, the findings could be developed into supplements or research chemicals — with $RIF holders sharing in those outcomes. More broadly, the project aims to demonstrate that blockchain-powered, community-funded science can accelerate research that traditional funding models overlook.

Frequently Asked Questions

$RIF is a Solana-based DeSci token that represents tokenized rights to longevity experiments testing the compound Rifampicin on Pump Science. Token holders fund research and receive real-time access to live-streamed experiment data.

Pump Science is a gamified longevity research platform developed by Molecule. It allows users to speculate on life-extending compounds, stream live experiment data, and propose longevity tests on model organisms.

Pump Science was developed by Molecule, a biotechnology research fundraising organization co-founded by Tyler Golato and Paul Kohlhaas. The platform and $RIF token launched in 2024.

Rifampicin is traditionally an antibiotic that has attracted interest for its potential anti-aging effects. In model organisms like C. elegans, it has been shown to activate cellular defense mechanisms that promote longer, healthier lifespans.

Holders gain fractional rights to the intellectual property produced by Rifampicin experiments. They also receive real-time access to live-streamed research data as experiments progress.

Transaction fees generated by $RIF token activity flow directly into funding ongoing scientific experiments. As experiments hit milestones, tokens are sold at new thresholds to finance further testing.

$RIF is built on the Solana blockchain, which provides high-speed, low-cost transactions well suited to the platform's active trading and community engagement model.

The DeSci sector is early-stage and carries volatility risks comparable to meme tokens. Additionally, longevity results in model organisms like worms may not translate to human outcomes, and tokenized IP rights exist in an uncertain regulatory environment.